Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
58056 Results Found
Coronavirus Update: New Information on Elective Surgery, PPE Conservation and Additional COVID-19 Issues
The Centers for Medicare & Medicaid Services (CMS) and Centers for Disease Control and Prevention (CDC), as well as other organi
Special Bulletin: Senate Passes the Coronavirus Aid, Relief, and Economic Security (CARES) Act
The Senate 96-0 passed the
Special Bulletin: HHS Announces How it Will Distribute Additional Funds to Providers Under CARES Act
The Department of Health and Human Services (HHS) today announced that it is distributing additional funds from the Public Health and Social Services Emergency Fund, beginning April 24.
AHA and ANA Outline Priorities for Next COVID-19 Relief Package
The AHA and American Nurses Association
HC3 Threat Briefing TLP White: Threat Modeling for Mobile Health Systems (April 30, 2020)
Advances in mobile health (mHealth), respectively Io THealth, are likely to reduce costs and improve the quality of healthcare.
Although telehealth systems may improve the quality
FDA authorizes emergency use of remdesivir
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
AHA and ANA urge Congress to provide additional support to hospitals, health systems and front-line caregivers responding to COVID-19
The AHA and American Nurses Association urged Congress to “act quickly to get needed resources into the health care system,” so that hospitals, nurses and physicians responding to COVID-19 are able to continue to provide treatments, front-line health care personnel are able to provide care and patients are able access health care services.
FDA authorizes emergency use of remdesivir
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
AHA, others urge DOJ to match CMS and OIG relief from certain fraud and abuse sanctions
The AHA, along with five other health organizations, urged Attorney General Bill Barr in providing “relief from the technical requirements of the Federal fraud and abuse laws and the unnecessary risk they pose to hospitals during a declared public health crisis.”
Blog: Spotlighting efforts to address COVID-19 disparities
Hospitals and health systems continue to provide care for our most vulnerable communities by addressing social needs, educating on COVID-19 risks and collaborating with community organizations to expand these efforts beyond their walls.